Tag: non-small cell lung cancer

New spatial profiling research shows that the positioning of cytotoxic T cells around tumor blood vessels predicts which non-small cell ...

A computational analysis of TCGA data has identified seven microRNAs that are both dysregulated in lung squamous cell carcinoma and ...

A new review explains how gut microbes program immunosuppressive regulatory B cells through cytokine and metabolite signals, with major implications ...

A stage IIIB lung squamous cell carcinoma patient achieved a pathological complete response after neoadjuvant sugemalimab plus chemotherapy, with biomarker ...

A sweeping review reveals how the RNA modification N6-methyladenosine orchestrates lung cancer progression, drug resistance, immunotherapy response, and survival prediction.

A two-decade bibliometric analysis of nearly 5,000 studies maps how small molecule drug research transformed lung cancer therapy, revealing China's ...

A new single-cell study identifies the transcription factor RBPJ and CD103-positive tissue-resident memory T cells as central drivers of successful ...

A phase II trial found that nanoparticle polymeric micellar paclitaxel combined with carboplatin and sintilimab produced an objective response rate ...

A new network meta-analysis of five trials involving 2,452 patients finds that triple therapy combining immunotherapy, antiangiogenic antibodies, and chemotherapy ...

New research shows the breast cancer drug lapatinib protects lung cancer cells from cysteine starvation-induced ferroptosis by restraining mitochondrial metabolic ...